VCIM
QNRX

Velan Capital Investment Management’s Quoin Pharmaceuticals QNRX Stock Holding History

Velan Capital Investment Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$560K Buy
+84,849
New +$769K 0.35% 27

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Velan Capital Investment Management's QNRX Position: Q1 2026 in Review

Velan Capital Investment Management opened a new position in Quoin Pharmaceuticals (QNRX) in Q1 2026: 84,849 shares worth $560K. The stake represents 0.35% of the portfolio and ranks #27 among its holdings.

22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • Velan Capital Investment Management held 84,849 shares of Quoin Pharmaceuticals worth $560K as of Q1 2026.
  • Quoin Pharmaceuticals was a new Velan Capital Investment Management position in Q1 2026.
  • Quoin Pharmaceuticals made up 0.35% of Velan Capital Investment Management's portfolio in Q1 2026, its #27 holding.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.